Tag Archives: Even

FDA moving to 'risk-based' inspections even as valsartan scare adds new wrinkle to oversight

FDA inspections of generic drug plants are on the rise and should continue to increase through 2019, Commissioner Scott Gottlieb said this week in a series of tweets.  But the game has changed, Gottlieb pointed out, with the number of pre-approval inspections growing more than surveillance inspections, in part to approve more generics in an effort… Read More »

In Brief: Mothers with Affective Illness (Even In Remission) Have Deficits in Emotional Processing

We have long known that postpartum depression may have negative effects on the child and may contribute to deficits in social development and emotional regulation.  Exactly what mediates these effects is not so clear; however, researchers have observed that depressed mothers tend to be less responsive to their children’s emotional cues and are more likely… Read More »